The unique contribution of blushing to the development of social anxiety disorder symptoms: results from a longitudinal study.


Journal

Journal of child psychology and psychiatry, and allied disciplines
ISSN: 1469-7610
Titre abrégé: J Child Psychol Psychiatry
Pays: England
ID NLM: 0375361

Informations de publication

Date de publication:
12 2020
Historique:
received: 16 08 2019
revised: 20 12 2019
accepted: 24 01 2020
pubmed: 23 2 2020
medline: 30 9 2021
entrez: 22 2 2020
Statut: ppublish

Résumé

Self-conscious emotional reactivity and its physiological marker - blushing has been proposed to be an etiological mechanism of social anxiety disorder (SAD), but so far, untested in longitudinal designs. This study tested, for the first time, whether self-conscious emotional reactivity (indexed as physiological blushing) contributes to the development of SAD symptoms over and above social behavioral inhibition (BI), which has been identified as the strongest predictor of SAD development in early childhood. One hundred fifteen children (45% boys) and their mothers and fathers participated at ages 2.5, 4.5, and 7.5 years. Social BI was observed at all time points in a stranger approach task, and physiological blushing (blood volume, blood pulse amplitude, and temperature increases) was measured during a public performance (singing) and watching back the performance at ages 4.5 and 7.5. Child early social anxiety was reported by both parents at 4.5 years, and SAD symptoms were diagnosed by clinicians and reported by both parents at 7.5 years. Higher social BI at 2.5 and 4.5 years predicted greater social anxiety at 4.5 years, which, in turn, predicted SAD symptoms at 7.5 years. Blushing (temperature increase) at 4.5 years predicted SAD symptoms at 7.5 years over and above the influence of social BI and early social anxiety. That blushing uniquely contributes to the development of SAD symptoms over and above social BI suggests two pathways to childhood SAD: one that entails early high social BI and an early onset of social anxiety symptoms, and the other that consists of heightened self-conscious emotional reactivity (i.e. blushing) in early childhood.

Sections du résumé

BACKGROUND
Self-conscious emotional reactivity and its physiological marker - blushing has been proposed to be an etiological mechanism of social anxiety disorder (SAD), but so far, untested in longitudinal designs. This study tested, for the first time, whether self-conscious emotional reactivity (indexed as physiological blushing) contributes to the development of SAD symptoms over and above social behavioral inhibition (BI), which has been identified as the strongest predictor of SAD development in early childhood.
METHODS
One hundred fifteen children (45% boys) and their mothers and fathers participated at ages 2.5, 4.5, and 7.5 years. Social BI was observed at all time points in a stranger approach task, and physiological blushing (blood volume, blood pulse amplitude, and temperature increases) was measured during a public performance (singing) and watching back the performance at ages 4.5 and 7.5. Child early social anxiety was reported by both parents at 4.5 years, and SAD symptoms were diagnosed by clinicians and reported by both parents at 7.5 years.
RESULTS
Higher social BI at 2.5 and 4.5 years predicted greater social anxiety at 4.5 years, which, in turn, predicted SAD symptoms at 7.5 years. Blushing (temperature increase) at 4.5 years predicted SAD symptoms at 7.5 years over and above the influence of social BI and early social anxiety.
CONCLUSIONS
That blushing uniquely contributes to the development of SAD symptoms over and above social BI suggests two pathways to childhood SAD: one that entails early high social BI and an early onset of social anxiety symptoms, and the other that consists of heightened self-conscious emotional reactivity (i.e. blushing) in early childhood.

Identifiants

pubmed: 32080848
doi: 10.1111/jcpp.13221
pmc: PMC7754350
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1339-1348

Informations de copyright

© 2020 The Authors. Journal of Child Psychology and Psychiatry published by John Wiley & Sons Ltd on behalf of Association for Child and Adolescent Mental Health.

Références

Acta Psychiatr Scand. 2002 Feb;105(2):84-93
pubmed: 11939957
Clin Psychol Rev. 2004 Nov;24(7):737-67
pubmed: 15501555
J Clin Child Adolesc Psychol. 2010;39(3):400-9
pubmed: 20419580
J Dev Behav Pediatr. 2007 Jun;28(3):225-33
pubmed: 17565290
Child Dev. 2019 Jul;90(4):1424-1441
pubmed: 31099053
Soc Psychiatry Psychiatr Epidemiol. 2006 May;41(5):394-9
pubmed: 16565920
Annu Rev Psychol. 2005;56:235-62
pubmed: 15709935
Behav Res Ther. 2007 Jul;45(7):1601-8
pubmed: 16890188
Behav Res Ther. 2018 Jul;106:1-7
pubmed: 29705596
Child Dev. 1994 Feb;65(1):129-37
pubmed: 8131643
Clin Psychol Rev. 2000 Jun;20(4):429-51
pubmed: 10832548
Cogn Behav Ther. 2007;36(4):193-209
pubmed: 18049945
Pharmacoeconomics. 2000 Jul;18(1):23-32
pubmed: 11010601
Front Hum Neurosci. 2015 Sep 23;9:489
pubmed: 26441590
J Am Acad Child Adolesc Psychiatry. 2012 Oct;51(10):1066-1075.e1
pubmed: 23021481
Psychophysiology. 1990 Nov;27(6):687-93
pubmed: 2100354
Psychol Methods. 2002 Jun;7(2):147-77
pubmed: 12090408
J Am Acad Child Adolesc Psychiatry. 2009 Sep;48(9):928-935
pubmed: 19625982
Behav Modif. 2000 Jan;24(1):102-29
pubmed: 10641370
Emotion. 2016 Jun;16(4):475-487
pubmed: 26641271
Psychophysiology. 2018 Oct;55(10):e13201
pubmed: 29876926
J Am Acad Child Adolesc Psychiatry. 2015 Jun;54(6):454-63
pubmed: 26004660
Soc Psychiatry Psychiatr Epidemiol. 2008 Apr;43(4):257-65
pubmed: 18084686
Dev Psychobiol. 2020 Jul;62(5):644-656
pubmed: 31680240
Child Dev. 2002 Mar-Apr;73(2):483-95
pubmed: 11949904
J Abnorm Child Psychol. 1995 Oct;23(5):607-18
pubmed: 8568083
J Abnorm Psychol. 2001 May;110(2):247-58
pubmed: 11358019
Infancy. 2015 Mar-Apr;20(2):160-188
pubmed: 25685095
J Child Psychol Psychiatry. 2016 Sep;57(9):1047-55
pubmed: 27133173
J Am Acad Child Adolesc Psychiatry. 1997 Apr;36(4):545-53
pubmed: 9100430
Science. 1988 Apr 8;240(4849):167-71
pubmed: 3353713
Depress Anxiety. 2010 Feb;27(2):168-89
pubmed: 20143427
Biol Psychol. 2009 May;81(2):86-94
pubmed: 19428972
Psychiatr Clin North Am. 2001 Dec;24(4):723-51
pubmed: 11723630
Clin Child Fam Psychol Rev. 2001 Mar;4(1):37-61
pubmed: 11388563
Dev Psychol. 2014 Oct;50(10):2311-2323
pubmed: 25181648
J Affect Disord. 2002 Apr;68(2-3):221-33
pubmed: 12063150
Psychol Bull. 1992 Nov;112(3):446-60
pubmed: 1438638

Auteurs

Milica Nikolić (M)

Research Institute of Child Development and Education, University of Amsterdam, Amsterdam, The Netherlands.

Mirjana Majdandžić (M)

Research Institute of Child Development and Education, University of Amsterdam, Amsterdam, The Netherlands.

Cristina Colonnesi (C)

Research Institute of Child Development and Education, University of Amsterdam, Amsterdam, The Netherlands.

Wieke de Vente (W)

Research Institute of Child Development and Education, University of Amsterdam, Amsterdam, The Netherlands.

Eline Möller (E)

Research Institute of Child Development and Education, University of Amsterdam, Amsterdam, The Netherlands.

Susan Bögels (S)

Developmental Psychology, University of Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH